Home > Insider Trading > Filing (0001104659-23-031814)

Filing Details

Accession Number:: 0001104659-23-031814
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2023-03-13 16:55:52
Reporting Period:: 2022-03-17

Accepted Time:: 2023-03-13 16:55:52
Original Submission Date:: 2022-03-21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609550	Inspire Medical Systems Inc.	INSP	Surgical & Medical Instruments & Apparatus (3841)	261377674

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1737136	P. Timothy Herbert	C/O Inspire Medical Systems, Inc. 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-03-17	18,731	$225.35	114,790	No	4	S	Direct
Common Stock	Disposition	2022-03-17	40	$226.04	114,790	No	4	S	Direct
Common Stock	Disposition	2022-03-17	1,193	$226.13	118,778	No	4	S	Indirect	By trust
Common Stock	Disposition	2022-03-17	36	$227.53	118,742	No	4	S	Indirect	By trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By trust
No	4	S	Indirect	By trust

Footnotes

This Form 4 amends and restates the previously reported sale transactions made by the Reporting Person that occurred on March 17, 2022 in order to reallocate such sales between the Reporting Person and a trust that is considered beneficially owned by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.00 to $225.995. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Reporting Person, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sale of shares directly held by the Reporting Person on March 17, 2022 by 1,229 shares, which is corrected herein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.04 to $226.65. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The amount of securities listed in Column 5 reflects the total shares held following the transaction based on the total reported in the Reporting Person's most recent Form 4, dated March 13, 2023.
Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.515 to $227.58. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.